© 2022 MJH Life Sciences™ and Drug Topics. All rights reserved.
Manufacturers extraordinaire: The top 10 drug firms of 2006
When measured by retail dollars, nine out of the top 10 companies were brand-name firms, with Teva Pharmaceuticals being the only generic representative that made the list. When measured by number of prescriptions, three out of the top 10 companies were generic drugmakers, including Teva, Mylan, and Watson Pharma.
Which pharmaceutical companies came out on top last year? When measured by retail dollars, nine out of the top 10 companies were brand-name firms, with Teva Pharmaceuticals being the only generic representative that made the list. When measured by number of prescriptions, three out of the top 10 companies were generic drugmakers, including Teva, Mylan, and Watson Pharma. Of the two lists, only one companyAstraZenecalogged double-digit increases by both dollars and units. What follows are two tables, one by dollars, one by units. The data were provided by market research firm Verispan.
Top 10 corporations by retail dollars in 2006
| % change from previous year | ||
| Pfizer | $20,413,717,265 | -1.8% |
| GlaxoSmithKline | 15,794,165,540 | 6.7 |
| AstraZeneca | 10,899,867,255 | 17.9 |
| Novartis | 10,108,785,889 | 9.2 |
| Teva Pharmaceuticals | 9,936,509,259 | 17.2 |
| Merck & Co. | 8,283,001,583 | -4.9 |
| Johnson & Johnson | 8,263,048,088 | -1.8 |
| Sanofi-Aventis | 6,149,228,271 | -5.8 |
| Abbott Labs | 5,992,405,684 | 6.2 |
| Eli Lilly | 5,842,618,115 | 9.2 |
Top 10 corporations by total Rxs in 2006
| % change from previous year | ||
| Teva Pharmaceuticals | 370,827,222 | 8.7% |
| Pfizer | 257,653,471 | -6.1 |
| Mylan | 235,582,276 | 7.7 |
| Novartis | 222,391,671 | 7.3 |
| Watson Pharma | 207,887,484 | 6.1 |
| GlaxoSmithKline | 104,542,833 | -8.8 |
| AstraZeneca | 99,732,796 | 11.5 |
| Mallinckrodt Medical | 82,903,489 | -8.6 |
| Merck & Co. | 81,640,147 | -6.7 |
| Abbott Labs | 72,684,001 | -8.8 |